Pediatrix Medical Group, Inc. (MD) intrinsic value & 10-year financials
Pediatrix Medical Group, Inc. (MD) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue shrank 5.5% a year to $1.9B, with an average return on invested capital of 3.1%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $27.38
- Market cap
- $2.3B
- Revenue (FY2025)
- $1.9B
- Revenue growth (10-yr CAGR)
- -5.5%
- ROIC (10-yr avg)
- 3.1%
- Free cash flow (FY2025)
- —
MD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.9B | $165.4M | $1.94 | — | 10.9% | 14.6% |
| FY2024 | $2.0B | -$99.1M | -$1.19 | — | -3.4% | -5.3% |
| FY2023 | $2.0B | -$60.4M | $0.73 | — | 0.4% | 0.5% |
| FY2022 | $2.0B | $66.3M | $0.79 | — | 8.8% | 8.8% |
| FY2021 | $1.9B | $131.0M | $1.53 | — | 10.6% | 11.5% |
| FY2020 | $1.7B | -$796.5M | -$9.55 | — | 5.7% | 4.3% |
| FY2019 | $3.5B | -$1.5B | -$17.94 | — | -32.3% | -26.1% |
| FY2018 | $3.6B | $268.6M | $2.93 | — | 12.2% | 6.6% |
| FY2017 | $3.5B | $320.4M | $3.45 | — | 13.9% | 8.1% |
| FY2016 | $3.2B | $324.9M | $3.49 | — | 18.0% | 8.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Pediatrix Medical Group, Inc. is facing top-line stagnation, with revenue contracting over the decade.
Pediatrix Medical Group, Inc. has historically struggled to out-earn its cost of capital, averaging just 3.1% ROIC.
Pediatrix Medical Group, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Pediatrix Medical Group, Inc. is modeled at -6.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-6.93 per share.